Mapping immunotherapy resistance pathways with biomedically-informed AI [Data4Cure @ PMWC 2019] - Data4Cure Blog
Despite the groundbreaking success of immune checkpoint inhibitor (ICI) therapies in hard-to-treat cancers, still only a fraction of patients show long-term clinical benefit. With the rapidly accumulating molecular, pathologic and clinical data from clinical trials and cancer cohorts, the question is how to best leverage these data to identify better biomarkers of ICI drug response,… Read more